07 Jan Dechra Veterinary Products expand their Equine portfolio
with addition of Zimeta® (dipyrone injection)
Dechra Veterinary Products is pleased to announce its exclusive marketing, sales and distribution agreement with Kindred Biosciences. Dechra has licensed the long-term distribution rights for Zimeta® (dipyrone injection), which will further bolster Dechra’s equine product portfolio. Zimeta is the first and only FDA-approved drug for the control of pyrexia in horses.
Read more here: Dechra Veterinary Products expands Equine portfolio